In conclusion, we identified a set of six CSF immunological proteins (CD5, IL12B, TNFB, TNFSF14, TNFRSF9 and MIP-1-alpha), each of them having discriminatory power in distinguishing MS from controls. This evidence concerns the gene CD5 and myeloid sarcoma.